
Design and synthesis of vidarabine prodrugs as antiviral agents
Keywords: Vidarabine; ara-A; Amino acid ester prodrug; Phosphoramidate prodrug; Antiviral activity; Selective protection of nucleoside; Levulinate ester; Oral bioavailability; Adenosine deaminase; Arahypoxanthine; ara-H; Caco-2 permeability